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Next Generation Sequencing has enabled a range of
applications to investigate nearly every facet of genomic
science including variant detection, transcriptome profil-
ing and epigenetic studies. Many of these applications
were previously either impractical or uneconomical by
Sanger sequencing. In particular, whole genome and
exome sequencing are now within the reach of an
increasing number of researchers due to continued
reduction in costs, improvements in workflow and
accessibility of appropriate technologies. Furthermore,
the improvements in data handling, storage and analysis
tools have contributed significantly in providing biolo-
gist-friendly methods to assemble reads and call
variants.
Here I will review the recent application of whole gen-
ome and exome sequencing in both clinical and
research environments for the study of breast cancer.
Specifically, a recent whole-genome investigation of 50
tumour-normal pairs sourced from oestrogen receptor
positive breast cancers will be explored. This study con-
firmed genes previously implicated in this type of can-
cer, as well as identifying 3 new candidates; MAP3K1,
ATR and MYST. To improve clinical outcomes, it is
hoped that whole genome sequencing in this study will
identify treatment-resistance mechanisms for cancers
sourced from women resistive to oestrogen-lowering
treatment.
Additional case studies will be used to highlight how
these techniques have advanced our understanding in
determining the treatment and subsequent clinical out-
comes for individuals suffering from rare diseases.
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